Vimarsana
Biggest News Aggregation in the World

Page 11 - Abilify Maintena News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Abilify Maintena. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Abilify Maintena Today - Breaking & Trending Today

Gold | Independent Agency, 2021 - Vimarsana News

Gold | Independent Agency, 2021

The Bloc

Otsuka partners with Sunovion, Sumitomo in neurology drug pact - Vimarsana News

Otsuka partners with Sunovion, Sumitomo in neurology drug pact

BioPharma

Decibel Therapeutics Appoints Dr. William H. Carson as Chairman of the Board of DirectorsDistinguished biopharma executive brings over 20 years of leadership in life sciences - Vimarsana News

Decibel Therapeutics Appoints Dr. William H. Carson as Chairman of the Board of DirectorsDistinguished biopharma executive brings over 20 years of leadership in life sciences

®, the first FDA-approved digital medicine. Bill currently serves as Chairman of the Board of Directors of OPDC and is also the Chairman of the Board of the Sozosei Foundation, a newly established Otsuka charitable organization focused on decriminalization of mental illness. He serves on the boards of Excision BioTherapeutics, Saama and Annexon Biosciences and is Trustee of the non-profit Internet2. He is Board Chair Emeritus of the Sphinx Organization, which advocates for parity and inclusion in the arts. “Bill is an eminent figure in the biopharmaceutical community with a proven track re...

Decibel Therapeutics Appoints - GuruFocus.com - Vimarsana News

Decibel Therapeutics Appoints - GuruFocus.com

®, the first FDA-approved digital medicine. Bill currently serves as Chairman of the Board of Directors of OPDC and is also the Chairman of the Board of the Sozosei Foundation, a newly established Otsuka charitable organization focused on decriminalization of mental illness. He serves on the boards of Excision BioTherapeutics, Saama and Annexon Biosciences and is Trustee of the non-profit Internet2. He is Board Chair Emeritus of the Sphinx Organization, which advocates for parity and inclusion in the arts. “Bill is an eminent figure in the biopharmaceutical community with a proven track re...

Otsuka creates Gen J in new Jynarque ads that aim to separate kidney from disease - Vimarsana News

Otsuka creates Gen J in new Jynarque ads that aim to separate kidney from disease

Otsuka wants to create a next generation of kidney disease patients—Gen J. Short for Generation J, with the J standing for Jynarque, they're the first age group who may be able to control progression of their rare kidney disease with the Otsuka med.